Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 5th edition, 486 pages

Free download


  Breast Cancer

  Free Subscription


Articles published in Oncogene

Retrieve available abstracts of 189 articles:
HTML format



Single Articles


    October 2020
  1. ABDULLAH A, Akhand SS, Paez JSP, Brown W, et al
    Epigenetic targeting of neuropilin-1 prevents bypass signaling in drug-resistant breast cancer.
    Oncogene. 2020 Oct 30. pii: 10.1038/s41388-020-01530.
    PubMed     Abstract available


  2. KUNG CP, Cottrell KA, Ryu S, Bramel ER, et al
    Evaluating the therapeutic potential of ADAR1 inhibition for triple-negative breast cancer.
    Oncogene. 2020 Oct 27. pii: 10.1038/s41388-020-01515.
    PubMed     Abstract available


  3. ZHENG X, Lu S, He Z, Huang H, et al
    MCU-dependent negative sorting of miR-4488 to extracellular vesicles enhances angiogenesis and promotes breast cancer metastatic colonization.
    Oncogene. 2020 Oct 16. pii: 10.1038/s41388-020-01514.
    PubMed     Abstract available


  4. LI Y, Li L, Qin J, Wu J, et al
    OSR1 phosphorylates the Smad2/3 linker region and induces TGF-beta1 autocrine to promote EMT and metastasis in breast cancer.
    Oncogene. 2020 Oct 13. pii: 10.1038/s41388-020-01499.
    PubMed     Abstract available


  5. ZHANG L, Qin Y, Wu G, Wang J, et al
    PRRG4 promotes breast cancer metastasis through the recruitment of NEDD4 and downregulation of Robo1.
    Oncogene. 2020 Oct 9. pii: 10.1038/s41388-020-01494.
    PubMed     Abstract available


  6. CHEN H, Libring S, Ruddraraju KV, Miao J, et al
    SHP2 is a multifunctional therapeutic target in drug resistant metastatic breast cancer.
    Oncogene. 2020 Oct 8. pii: 10.1038/s41388-020-01488.
    PubMed     Abstract available


    September 2020
  7. WANG G, Wang J, Chang A, Cheng D, et al
    Her2 promotes early dissemination of breast cancer by suppressing the p38 pathway through Skp2-mediated proteasomal degradation of Tpl2.
    Oncogene. 2020 Sep 28. pii: 10.1038/s41388-020-01481.
    PubMed     Abstract available


  8. ZHU J, Li X, Su P, Xue M, et al
    The ubiquitin ligase RNF181 stabilizes ERalpha and modulates breast cancer progression.
    Oncogene. 2020 Sep 24. pii: 10.1038/s41388-020-01464.
    PubMed     Abstract available


  9. LI LY, Chen XS, Wang KS, Guan YD, et al
    RSK2 protects human breast cancer cells under endoplasmic reticulum stress through activating AMPKalpha2-mediated autophagy.
    Oncogene. 2020 Sep 21. pii: 10.1038/s41388-020-01447.
    PubMed     Abstract available


  10. DOHENY D, Sirkisoon S, Carpenter RL, Aguayo NR, et al
    Combined inhibition of JAK2-STAT3 and SMO-GLI1/tGLI1 pathways suppresses breast cancer stem cells, tumor growth, and metastasis.
    Oncogene. 2020 Sep 14. pii: 10.1038/s41388-020-01454.
    PubMed     Abstract available


    August 2020
  11. MURRAY AS, Hyland TE, Sala-Hamrick KE, Mackinder JR, et al
    The cell-surface anchored serine protease TMPRSS13 promotes breast cancer progression and resistance to chemotherapy.
    Oncogene. 2020 Aug 31. pii: 10.1038/s41388-020-01436.
    PubMed     Abstract available


  12. VERNIER M, McGuirk S, Dufour CR, Wan L, et al
    Inhibition of DNMT1 and ERRalpha crosstalk suppresses breast cancer via derepression of IRF4.
    Oncogene. 2020 Aug 27. pii: 10.1038/s41388-020-01438.
    PubMed     Abstract available


  13. WANG J, Wang G, Cheng D, Huang S, et al
    Her2 promotes early dissemination of breast cancer by suppressing the p38-MK2-Hsp27 pathway that is targetable by Wip1 inhibition.
    Oncogene. 2020 Aug 26. pii: 10.1038/s41388-020-01437.
    PubMed     Abstract available


  14. CHERVO MF, Cordo Russo RI, Petrillo E, Izzo F, et al
    Canonical ErbB-2 isoform and ErbB-2 variant c located in the nucleus drive triple negative breast cancer growth.
    Oncogene. 2020 Aug 25. pii: 10.1038/s41388-020-01430.
    PubMed     Abstract available


  15. LIU H, Gruber CW, Alewood PF, Moller A, et al
    The oxytocin receptor signalling system and breast cancer: a critical review.
    Oncogene. 2020 Aug 11. pii: 10.1038/s41388-020-01415.
    PubMed     Abstract available


  16. LIN B, Li Y, Wang T, Qiu Y, et al
    CRMP2 is a therapeutic target that suppresses the aggressiveness of breast cancer cells by stabilizing RECK.
    Oncogene. 2020 Aug 10. pii: 10.1038/s41388-020-01412.
    PubMed     Abstract available


    July 2020
  17. YANG H, Geng YH, Wang P, Yang H, et al
    Extracellular ATP promotes breast cancer invasion and chemoresistance via SOX9 signaling.
    Oncogene. 2020 Jul 28. pii: 10.1038/s41388-020-01402.
    PubMed     Abstract available


  18. BUSCHHAUS JM, Humphries BA, Eckley SS, Robison TH, et al
    Targeting disseminated estrogen-receptor-positive breast cancer cells in bone marrow.
    Oncogene. 2020 Jul 16. pii: 10.1038/s41388-020-01391.
    PubMed     Abstract available


    June 2020
  19. HRUSCHKA N, Kalisz M, Subijana M, Grana-Castro O, et al
    The GATA3 X308_Splice breast cancer mutation is a hormone context-dependent oncogenic driver.
    Oncogene. 2020 Jun 25. pii: 10.1038/s41388-020-1376.
    PubMed     Abstract available


  20. SUN T, Wu Z, Wang X, Wang Y, et al
    LNC942 promoting METTL14-mediated m(6)A methylation in breast cancer cell proliferation and progression.
    Oncogene. 2020 Jun 23. pii: 10.1038/s41388-020-1338.
    PubMed     Abstract available


  21. JIANG K, Liu P, Xu H, Liang D, et al
    SASH1 suppresses triple-negative breast cancer cell invasion through YAP-ARHGAP42-actin axis.
    Oncogene. 2020 Jun 10. pii: 10.1038/s41388-020-1356.
    PubMed     Abstract available


  22. AN P, Chen F, Li Z, Ling Y, et al
    HDAC8 promotes the dissemination of breast cancer cells via AKT/GSK-3beta/Snail signals.
    Oncogene. 2020 Jun 4. pii: 10.1038/s41388-020-1337.
    PubMed     Abstract available


    May 2020
  23. SIMOES BM, Santiago-Gomez A, Chiodo C, Moreira T, et al
    Targeting STAT3 signaling using stabilised sulforaphane (SFX-01) inhibits endocrine resistant stem-like cells in ER-positive breast cancer.
    Oncogene. 2020 May 30. pii: 10.1038/s41388-020-1335.
    PubMed     Abstract available


  24. MEYER-SCHALLER N, Tiede S, Ivanek R, Diepenbruck M, et al
    A dual role of Irf1 in maintaining epithelial identity but also enabling EMT and metastasis formation of breast cancer cells.
    Oncogene. 2020 May 14. pii: 10.1038/s41388-020-1326.
    PubMed     Abstract available


  25. JIANG M, Zhang W, Zhang R, Liu P, et al
    Cancer exosome-derived miR-9 and miR-181a promote the development of early-stage MDSCs via interfering with SOCS3 and PIAS3 respectively in breast cancer.
    Oncogene. 2020 May 12. pii: 10.1038/s41388-020-1322.
    PubMed     Abstract available


  26. SHMULEVICH R, Nissim TB, Wolf I, Merenbakh-Lamin K, et al
    Klotho rewires cellular metabolism of breast cancer cells through alteration of calcium shuttling and mitochondrial activity.
    Oncogene. 2020 May 12. pii: 10.1038/s41388-020-1313.
    PubMed     Abstract available


  27. YONEDA A, Minomi K, Tamura Y
    HSP47 promotes metastasis of breast cancer by interacting with myosin IIA via the unfolded protein response transducer IRE1alpha.
    Oncogene. 2020 May 4. pii: 10.1038/s41388-020-1311.
    PubMed     Abstract available


    April 2020
  28. SUNDQVIST A, Vasilaki E, Voytyuk O, Bai Y, et al
    TGFbeta and EGF signaling orchestrates the AP-1- and p63 transcriptional regulation of breast cancer invasiveness.
    Oncogene. 2020 Apr 29. pii: 10.1038/s41388-020-1299.
    PubMed     Abstract available


  29. CASSANDRI M, Butera A, Amelio I, Lena AM, et al
    ZNF750 represses breast cancer invasion via epigenetic control of prometastatic genes.
    Oncogene. 2020 Apr 20. pii: 10.1038/s41388-020-1277.
    PubMed     Abstract available


  30. KLUZ PN, Kolb R, Xie Q, Borcherding N, et al
    Cancer cell-intrinsic function of CD177 in attenuating beta-catenin signaling.
    Oncogene. 2020;39:2877-2889.
    PubMed     Abstract available


  31. JEANNOT E, Darrigues L, Michel M, Stern MH, et al
    A single droplet digital PCR for ESR1 activating mutations detection in plasma.
    Oncogene. 2020;39:2987-2995.
    PubMed     Abstract available


    March 2020
  32. HE J, McLaughlin RP, van der Beek L, Canisius S, et al
    Integrative analysis of genomic amplification-dependent expression and loss-of-function screen identifies ASAP1 as a driver gene in triple-negative breast cancer progression.
    Oncogene. 2020 Mar 31. pii: 10.1038/s41388-020-1279.
    PubMed     Abstract available


  33. ARNOLD JM, Gu F, Ambati CR, Rasaily U, et al
    Correction: UDP-glucose 6-dehydrogenase regulates hyaluronic acid production and promotes breast cancer progression.
    Oncogene. 2020 Mar 25. pii: 10.1038/s41388-020-1252.
    PubMed     Abstract available


    February 2020
  34. YOE J, Kim D, Kim S, Lee Y, et al
    Capicua restricts cancer stem cell-like properties in breast cancer cells.
    Oncogene. 2020 Feb 27. pii: 10.1038/s41388-020-1230.
    PubMed     Abstract available


  35. BROWN TP, Bhattacharjee P, Ramachandran S, Sivaprakasam S, et al
    The lactate receptor GPR81 promotes breast cancer growth via a paracrine mechanism involving antigen-presenting cells in the tumor microenvironment.
    Oncogene. 2020 Feb 19. pii: 10.1038/s41388-020-1216.
    PubMed     Abstract available


  36. BESSOU M, Lopez J, Gadet R, Deygas M, et al
    The apoptosis inhibitor Bcl-xL controls breast cancer cell migration through mitochondria-dependent reactive oxygen species production.
    Oncogene. 2020 Feb 17. pii: 10.1038/s41388-020-1212.
    PubMed     Abstract available


  37. GONG C, Tsoi H, Mok KC, Cheung J, et al
    Phosphorylation independent eIF4E translational reprogramming of selective mRNAs determines tamoxifen resistance in breast cancer.
    Oncogene. 2020 Feb 17. pii: 10.1038/s41388-020-1210.
    PubMed     Abstract available


  38. FARHAT D, Ghayad SE, Icard P, Le Romancer M, et al
    Lipoic acid-induced oxidative stress abrogates IGF-1R maturation by inhibiting the CREB/furin axis in breast cancer cell lines.
    Oncogene. 2020 Feb 14. pii: 10.1038/s41388-020-1211.
    PubMed     Abstract available


  39. KENNEDY SP, O'Neill M, Cunningham D, Morris PG, et al
    Preclinical evaluation of a novel triple-acting PIM/PI3K/mTOR inhibitor, IBL-302, in breast cancer.
    Oncogene. 2020 Feb 10. pii: 10.1038/s41388-020-1202.
    PubMed     Abstract available


  40. TARULLO SE, Hill RC, Hansen KC, Behbod F, et al
    Postpartum breast cancer progression is driven by semaphorin 7a-mediated invasion and survival.
    Oncogene. 2020 Feb 4. pii: 10.1038/s41388-020-1192.
    PubMed     Abstract available


    January 2020
  41. RAN R, Harrison H, Syamimi Ariffin N, Ayub R, et al
    A role for CBFbeta in maintaining the metastatic phenotype of breast cancer cells.
    Oncogene. 2020 Jan 31. pii: 10.1038/s41388-020-1170.
    PubMed     Abstract available


  42. ZHANG J, Lin X, Wu L, Huang JJ, et al
    Aurora B induces epithelial-mesenchymal transition by stabilizing Snail1 to promote basal-like breast cancer metastasis.
    Oncogene. 2020 Jan 29. pii: 10.1038/s41388-020-1165.
    PubMed     Abstract available


  43. WU X, Zhang X, Yu L, Zhang C, et al
    Zinc finger protein 367 promotes metastasis by inhibiting the Hippo pathway in breast cancer.
    Oncogene. 2020 Jan 27. pii: 10.1038/s41388-020-1166.
    PubMed     Abstract available


  44. MCGINN O, Ward AV, Fettig LM, Riley D, et al
    Cytokeratin 5 alters beta-catenin dynamics in breast cancer cells.
    Oncogene. 2020 Jan 27. pii: 10.1038/s41388-020-1164.
    PubMed     Abstract available


  45. WU HJ, Hao M, Yeo SK, Guan JL, et al
    FAK signaling in cancer-associated fibroblasts promotes breast cancer cell migration and metastasis by exosomal miRNAs-mediated intercellular communication.
    Oncogene. 2020 Jan 27. pii: 10.1038/s41388-020-1162.
    PubMed     Abstract available


  46. DIAS MM, Adamoski D, Dos Reis LM, Ascencao CFR, et al
    GLS2 is protumorigenic in breast cancers.
    Oncogene. 2020;39:690-702.
    PubMed     Abstract available


  47. SUNG JS, Kang CW, Kang S, Jang Y, et al
    ITGB4-mediated metabolic reprogramming of cancer-associated fibroblasts.
    Oncogene. 2020;39:664-676.
    PubMed     Abstract available


  48. SAVA GP, Fan H, Fisher RA, Lusvarghi S, et al
    ABC-transporter upregulation mediates resistance to the CDK7 inhibitors THZ1 and ICEC0942.
    Oncogene. 2020;39:651-663.
    PubMed     Abstract available


    December 2019
  49. FANG R, Xu F, Shi H, Wu Y, et al
    LAMTOR5 raises abnormal initiation of O-glycosylation in breast cancer metastasis via modulating GALNT1 activity.
    Oncogene. 2019 Dec 13. pii: 10.1038/s41388-019-1146.
    PubMed     Abstract available


  50. LI K, Zhang J, Tian Y, He Y, et al
    The Wnt/beta-catenin/VASP positive feedback loop drives cell proliferation and migration in breast cancer.
    Oncogene. 2019 Dec 12. pii: 10.1038/s41388-019-1145.
    PubMed     Abstract available


  51. NEELI PK, Gollavilli PN, Mallappa S, Hari SG, et al
    A novel metadherinDelta7 splice variant enhances triple negative breast cancer aggressiveness by modulating mitochondrial function via NFkB-SIRT3 axis.
    Oncogene. 2019 Dec 5. pii: 10.1038/s41388-019-1126.
    PubMed     Abstract available


  52. QIAN T, Liu C, Ding Y, Guo C, et al
    PINCH-1 interacts with myoferlin to promote breast cancer progression and metastasis.
    Oncogene. 2019 Dec 4. pii: 10.1038/s41388-019-1135.
    PubMed     Abstract available


    November 2019
  53. AMES S, Andring JT, McKenna R, Becker HM, et al
    CAIX forms a transport metabolon with monocarboxylate transporters in human breast cancer cells.
    Oncogene. 2019 Nov 13. pii: 10.1038/s41388-019-1098.
    PubMed     Abstract available


  54. BONETTI P, Climent M, Panebianco F, Tordonato C, et al
    Correction: Dual role for miR-34a in the control of early progenitor proliferation and commitment in the mammary gland and in breast cancer.
    Oncogene. 2019 Nov 8. pii: 10.1038/s41388-019-1094.
    PubMed     Abstract available


  55. CHENG R, Billet S, Liu C, Haldar S, et al
    Periodontal inflammation recruits distant metastatic breast cancer cells by increasing myeloid-derived suppressor cells.
    Oncogene. 2019 Nov 4. pii: 10.1038/s41388-019-1084.
    PubMed     Abstract available


    October 2019
  56. CLEMENTS ME, Johnson RW
    PREX1 drives spontaneous bone dissemination of ER+ breast cancer cells.
    Oncogene. 2019 Oct 21. pii: 10.1038/s41388-019-1064.
    PubMed     Abstract available


  57. FRANKE CM, Gu VW, Grimm BG, Cassady VC, et al
    TFAP2C regulates carbonic anhydrase XII in human breast cancer.
    Oncogene. 2019 Oct 21. pii: 10.1038/s41388-019-1062.
    PubMed     Abstract available


  58. YOUSEFI H, Maheronnaghsh M, Molaei F, Mashouri L, et al
    Long noncoding RNAs and exosomal lncRNAs: classification, and mechanisms in breast cancer metastasis and drug resistance.
    Oncogene. 2019 Oct 10. pii: 10.1038/s41388-019-1040.
    PubMed     Abstract available


  59. WILLIAMS CB, Phelps-Polirer K, Dingle IP, Williams CJ, et al
    HUNK phosphorylates EGFR to regulate breast cancer metastasis.
    Oncogene. 2019 Oct 9. pii: 10.1038/s41388-019-1046.
    PubMed     Abstract available


    September 2019
  60. CHANG YW, Tseng CF, Wang MY, Chang WC, et al
    Correction: Deacetylation of HSPA5 by HDAC6 leads to GP78-mediated HSPA5 ubiquitination at K447 and suppresses metastasis of breast cancer.
    Oncogene. 2019 Sep 19. pii: 10.1038/s41388-019-0981.
    PubMed     Abstract available


  61. YANG T, Ren C, Qiao P, Han X, et al
    Correction: PIM2-mediated phosphorylation of hexokinase 2 is critical for tumor growth and paclitaxel resistance in breast cancer.
    Oncogene. 2019 Sep 11. pii: 10.1038/s41388-019-0982.
    PubMed     Abstract available


    August 2019
  62. LU X, Liu R, Wang M, Kumar AK, et al
    MicroRNA-140 impedes DNA repair by targeting FEN1 and enhances chemotherapeutic response in breast cancer.
    Oncogene. 2019 Aug 30. pii: 10.1038/s41388-019-0986.
    PubMed     Abstract available


  63. SIRKISOON SR, Carpenter RL, Rimkus T, Doheny D, et al
    TGLI1 transcription factor mediates breast cancer brain metastasis via activating metastasis-initiating cancer stem cells and astrocytes in the tumor microenvironment.
    Oncogene. 2019 Aug 28. pii: 10.1038/s41388-019-0959.
    PubMed     Abstract available


  64. CEBRIA-COSTA JP, Pascual-Reguant L, Gonzalez-Perez A, Serra-Bardenys G, et al
    LOXL2-mediated H3K4 oxidation reduces chromatin accessibility in triple-negative breast cancer cells.
    Oncogene. 2019 Aug 28. pii: 10.1038/s41388-019-0969.
    PubMed     Abstract available


  65. YAO N, Fu Y, Chen L, Liu Z, et al
    Long non-coding RNA NONHSAT101069 promotes epirubicin resistance, migration, and invasion of breast cancer cells through NONHSAT101069/miR-129-5p/Twist1 axis.
    Oncogene. 2019 Aug 23. pii: 10.1038/s41388-019-0904.
    PubMed     Abstract available


  66. HU X, Xiang D, Xie Y, Tao L, et al
    LSD1 suppresses invasion, migration and metastasis of luminal breast cancer cells via activation of GATA3 and repression of TRIM37 expression.
    Oncogene. 2019 Aug 13. pii: 10.1038/s41388-019-0923.
    PubMed     Abstract available


  67. PIQUE L, Martinez de Paz A, Pineyro D, Martinez-Cardus A, et al
    Epigenetic inactivation of the splicing RNA-binding protein CELF2 in human breast cancer.
    Oncogene. 2019 Aug 13. pii: 10.1038/s41388-019-0936.
    PubMed     Abstract available


  68. LIANG Y, Song X, Li Y, Su P, et al
    circKDM4C suppresses tumor progression and attenuates doxorubicin resistance by regulating miR-548p/PBLD axis in breast cancer.
    Oncogene. 2019 Aug 12. pii: 10.1038/s41388-019-0926.
    PubMed     Abstract available


  69. JALLOW F, O'Leary KA, Rugowski DE, Guerrero JF, et al
    Dynamic interactions between the extracellular matrix and estrogen activity in progression of ER+ breast cancer.
    Oncogene. 2019 Aug 12. pii: 10.1038/s41388-019-0941.
    PubMed     Abstract available


  70. CASLINI C, Hong S, Ban YJ, Chen XS, et al
    HDAC7 regulates histone 3 lysine 27 acetylation and transcriptional activity at super-enhancer-associated genes in breast cancer stem cells.
    Oncogene. 2019 Aug 2. pii: 10.1038/s41388-019-0897.
    PubMed     Abstract available


    July 2019
  71. CORDERO A, Kanojia D, Miska J, Panek WK, et al
    FABP7 is a key metabolic regulator in HER2+ breast cancer brain metastasis.
    Oncogene. 2019 Jul 19. pii: 10.1038/s41388-019-0893.
    PubMed     Abstract available


  72. ARNOLD JM, Gu F, Ambati CR, Rasaily U, et al
    UDP-glucose 6-dehydrogenase regulates hyaluronic acid production and promotes breast cancer progression.
    Oncogene. 2019 Jul 15. pii: 10.1038/s41388-019-0885.
    PubMed     Abstract available


  73. QIAN JY, Gao J, Sun X, Cao MD, et al
    KIAA1429 acts as an oncogenic factor in breast cancer by regulating CDK1 in an N6-methyladenosine-independent manner.
    Oncogene. 2019 Jul 8. pii: 10.1038/s41388-019-0861.
    PubMed     Abstract available


    June 2019
  74. CRAWFORD NT, McIntyre AJ, McCormick A, D'Costa ZC, et al
    TBX2 interacts with heterochromatin protein 1 to recruit a novel repression complex to EGR1-targeted promoters to drive the proliferation of breast cancer cells.
    Oncogene. 2019 Jun 28. pii: 10.1038/s41388-019-0853.
    PubMed     Abstract available


  75. ZHU Y, Xie M, Meng Z, Leung LK, et al
    Knockdown of TM9SF4 boosts ER stress to trigger cell death of chemoresistant breast cancer cells.
    Oncogene. 2019 Jun 27. pii: 10.1038/s41388-019-0846.
    PubMed     Abstract available


  76. LEE E, Ouzounova M, Piranlioglu R, Ma MT, et al
    Correction: The pleiotropic effects of TNFalpha in breast cancer subtypes is regulated by TNFAIP3/A20.
    Oncogene. 2019 Jun 13. pii: 10.1038/s41388-019-0838.
    PubMed     Abstract available


    May 2019
  77. HERNANDEZ-PEREZ S, Cabrera E, Salido E, Lim M, et al
    Correction: DUB3 and USP7 de-ubiquitinating enzymes control replication inhibitor Geminin: molecular characterization and associations with breast cancer.
    Oncogene. 2019 May 8. pii: 10.1038/s41388-019-0753.
    PubMed     Abstract available


  78. SORIA-VALLES C, Gutierrez-Fernandez A, Guiu M, Mari B, et al
    Correction: The anti-metastatic activity of collagenase-2 in breast cancer cells is mediated by a signaling pathway involving decorin and miR-21.
    Oncogene. 2019 May 3. pii: 10.1038/s41388-019-0825.
    PubMed     Abstract available


  79. GUNARATNA RT, Santos A, Luo L, Nagi C, et al
    Dynamic role of the codon 72 p53 single-nucleotide polymorphism in mammary tumorigenesis in a humanized mouse model.
    Oncogene. 2019;38:3535-3550.
    PubMed     Abstract available


  80. TEW BY, Legendre C, Gooden GC, Johnson KN, et al
    Isolation and characterization of patient-derived CNS metastasis-associated stromal cell lines.
    Oncogene. 2019;38:4002-4014.
    PubMed     Abstract available


  81. DAS S, Nair RS, Mishra R, Sondarva G, et al
    Mixed lineage kinase 3 promotes breast tumorigenesis via phosphorylation and activation of p21-activated kinase 1.
    Oncogene. 2019;38:3569-3584.
    PubMed     Abstract available


  82. WILLIAMS KC, Cepeda MA, Javed S, Searle K, et al
    Invadopodia are chemosensing protrusions that guide cancer cell extravasation to promote brain tropism in metastasis.
    Oncogene. 2019;38:3598-3615.
    PubMed     Abstract available


    April 2019
  83. YANG RM, Nanayakkara D, Kalimutho M, Mitra P, et al
    MYB regulates the DNA damage response and components of the homology-directed repair pathway in human estrogen receptor-positive breast cancer cells.
    Oncogene. 2019 Apr 10. pii: 10.1038/s41388-019-0789.
    PubMed     Abstract available


  84. TAN BS, Yang MC, Singh S, Chou YC, et al
    LncRNA NORAD is repressed by the YAP pathway and suppresses lung and breast cancer metastasis by sequestering S100P.
    Oncogene. 2019 Apr 9. pii: 10.1038/s41388-019-0812.
    PubMed     Abstract available


  85. HE M, Jin Q, Chen C, Liu Y, et al
    The miR-186-3p/EREG axis orchestrates tamoxifen resistance and aerobic glycolysis in breast cancer cells.
    Oncogene. 2019 Apr 9. pii: 10.1038/s41388-019-0817.
    PubMed     Abstract available


  86. YOSHINO Y, Qi H, Kanazawa R, Sugamata M, et al
    RACK1 regulates centriole duplication by controlling localization of BRCA1 to the centrosome in mammary tissue-derived cells.
    Oncogene. 2019;38:3077-3092.
    PubMed     Abstract available


  87. GOMES AM, Carron EC, Mills KL, Dow AM, et al
    Stromal Gas6 promotes the progression of premalignant mammary cells.
    Oncogene. 2019;38:2437-2450.
    PubMed     Abstract available


    March 2019
  88. KARADEDOU CT, Gomes AR, Chen J, Petkovic M, et al
    Correction: FOXO3a represses VEGF expression through FOXM1-dependent and -independent mechanisms in breast cancer.
    Oncogene. 2019 Mar 13. pii: 10.1038/s41388-019-0770.
    PubMed     Abstract available


  89. GOODING AJ, Zhang B, Gunawardane L, Beard A, et al
    The lncRNA BORG facilitates the survival and chemoresistance of triple-negative breast cancers.
    Oncogene. 2019;38:2020-2041.
    PubMed     Abstract available


  90. MARQUES M, Jangal M, Wang LC, Kazanets A, et al
    Oncogenic activity of poly (ADP-ribose) glycohydrolase.
    Oncogene. 2019;38:2177-2191.
    PubMed     Abstract available


  91. FEDOROVA O, Petukhov A, Daks A, Shuvalov O, et al
    Orphan receptor NR4A3 is a novel target of p53 that contributes to apoptosis.
    Oncogene. 2019;38:2108-2122.
    PubMed     Abstract available


    February 2019
  92. SUN Y, Ding Y, Guo C, Liu C, et al
    alpha-Parvin promotes breast cancer progression and metastasis through interaction with G3BP2 and regulation of TWIST1 signaling.
    Oncogene. 2019 Feb 25. pii: 10.1038/s41388-019-0762.
    PubMed     Abstract available


  93. CONTRERAS-ZARATE MJ, Day NL, Ormond DR, Borges VF, et al
    Estradiol induces BDNF/TrkB signaling in triple-negative breast cancer to promote brain metastases.
    Oncogene. 2019 Feb 22. pii: 10.1038/s41388-019-0756.
    PubMed     Abstract available


  94. BLOCK I, Muller C, Sdogati D, Pedersen H, et al
    CFP suppresses breast cancer cell growth by TES-mediated upregulation of the transcription factor DDIT3.
    Oncogene. 2019 Feb 12. pii: 10.1038/s41388-019-0739.
    PubMed     Abstract available


  95. KANG MH, Jeong KJ, Kim WY, Lee HJ, et al
    Correction: Musashi RNA-binding protein 2 regulates estrogen receptor 1 function in breast cancer.
    Oncogene. 2019 Feb 4. pii: 10.1038/s41388-019-0721.
    PubMed     Abstract available


  96. HUANG X, Wang XN, Yuan XD, Wu WY, et al
    XIAP facilitates breast and colon carcinoma growth via promotion of p62 depletion through ubiquitination-dependent proteasomal degradation.
    Oncogene. 2019;38:1448-1460.
    PubMed     Abstract available


  97. INESS AN, Felthousen J, Ananthapadmanabhan V, Sesay F, et al
    The cell cycle regulatory DREAM complex is disrupted by high expression of oncogenic B-Myb.
    Oncogene. 2019;38:1080-1092.
    PubMed     Abstract available


    January 2019
  98. CASTAGNOLI L, Cancila V, Cordoba-Romero SL, Faraci S, et al
    WNT signaling modulates PD-L1 expression in the stem cell compartment of triple-negative breast cancer.
    Oncogene. 2019 Jan 31. pii: 10.1038/s41388-019-0700.
    PubMed     Abstract available


  99. ZHAO Y, Qiao S, Hou X, Tian H, et al
    Bioengineered tumor microenvironments with naked mole rats high-molecular-weight hyaluronan induces apoptosis in breast cancer cells.
    Oncogene. 2019 Jan 30. pii: 10.1038/s41388-019-0719.
    PubMed     Abstract available


  100. WOOSLEY AN, Dalton AC, Hussey GS, Howley BV, et al
    TGFbeta promotes breast cancer stem cell self-renewal through an ILEI/LIFR signaling axis.
    Oncogene. 2019 Jan 28. pii: 10.1038/s41388-019-0703.
    PubMed     Abstract available


  101. CHOUCAIR A, Pham TH, Omarjee S, Jacquemetton J, et al
    The arginine methyltransferase PRMT1 regulates IGF-1 signaling in breast cancer.
    Oncogene. 2019 Jan 28. pii: 10.1038/s41388-019-0694.
    PubMed     Abstract available


  102. ZHOU XL, Zhu CY, Wu ZG, Guo X, et al
    The oncoprotein HBXIP competitively binds KEAP1 to activate NRF2 and enhance breast cancer cell growth and metastasis.
    Oncogene. 2019 Jan 28. pii: 10.1038/s41388-019-0698.
    PubMed     Abstract available


  103. KOHLER M, Ehrenfeld S, Halbach S, Lauinger M, et al
    B-Raf deficiency impairs tumor initiation and progression in a murine breast cancer model.
    Oncogene. 2019 Jan 18. pii: 10.1038/s41388-018-0663.
    PubMed     Abstract available


  104. KIM I, Shin SH, Lee JE, Park JW, et al
    Oxygen sensor FIH inhibits HACE1-dependent ubiquitination of Rac1 to enhance metastatic potential in breast cancer cells.
    Oncogene. 2019 Jan 18. pii: 10.1038/s41388-019-0676.
    PubMed     Abstract available


  105. PANAGOPOULOU M, Karaglani M, Balgkouranidou I, Biziota E, et al
    Circulating cell-free DNA in breast cancer: size profiling, levels, and methylation patterns lead to prognostic and predictive classifiers.
    Oncogene. 2019 Jan 14. pii: 10.1038/s41388-018-0660.
    PubMed     Abstract available


  106. MANN J, Githaka JM, Buckland TW, Yang N, et al
    Non-canonical BAD activity regulates breast cancer cell and tumor growth via 14-3-3 binding and mitochondrial metabolism.
    Oncogene. 2019 Jan 11. pii: 10.1038/s41388-018-0673.
    PubMed     Abstract available


  107. DOMENICI G, Aurrekoetxea-Rodriguez I, Simoes BM, Rabano M, et al
    A Sox2-Sox9 signalling axis maintains human breast luminal progenitor and breast cancer stem cells.
    Oncogene. 2019 Jan 8. pii: 10.1038/s41388-018-0656.
    PubMed     Abstract available


    December 2018
  108. MARUSIAK AA, Prelowska MK, Mehlich D, Lazniewski M, et al
    Upregulation of MLK4 promotes migratory and invasive potential of breast cancer cells.
    Oncogene. 2018 Dec 14. pii: 10.1038/s41388-018-0618.
    PubMed     Abstract available


  109. LAN Q, Peyvandi S, Duffey N, Huang YT, et al
    Type I interferon/IRF7 axis instigates chemotherapy-induced immunological dormancy in breast cancer.
    Oncogene. 2018 Dec 13. pii: 10.1038/s41388-018-0624.
    PubMed     Abstract available


  110. PARONI G, Bolis M, Zanetti A, Ubezio P, et al
    HER2-positive breast-cancer cell lines are sensitive to KDM5 inhibition: definition of a gene-expression model for the selection of sensitive cases.
    Oncogene. 2018 Dec 11. pii: 10.1038/s41388-018-0620.
    PubMed     Abstract available


  111. MA A, Tang M, Zhang L, Wang B, et al
    USP1 inhibition destabilizes KPNA2 and suppresses breast cancer metastasis.
    Oncogene. 2018 Dec 7. pii: 10.1038/s41388-018-0590.
    PubMed     Abstract available


  112. GIANNI M, Terao M, Kurosaki M, Paroni G, et al
    S100A3 a partner protein regulating the stability/activity of RARalpha and PML-RARalpha in cellular models of breast/lung cancer and acute myeloid leukemia.
    Oncogene. 2018 Dec 7. pii: 10.1038/s41388-018-0599.
    PubMed     Abstract available


  113. KOLB R, Kluz P, Tan ZW, Borcherding N, et al
    Obesity-associated inflammation promotes angiogenesis and breast cancer via angiopoietin-like 4.
    Oncogene. 2018 Dec 5. pii: 10.1038/s41388-018-0592.
    PubMed     Abstract available


    November 2018
  114. VARGAS G, Bouchet M, Bouazza L, Reboul P, et al
    ERRalpha promotes breast cancer cell dissemination to bone by increasing RANK expression in primary breast tumors.
    Oncogene. 2018 Nov 26. pii: 10.1038/s41388-018-0579.
    PubMed     Abstract available


  115. ZHAO H, Martin E, Matalkah F, Shah N, et al
    Conditional knockout of SHP2 in ErbB2 transgenic mice or inhibition in HER2-amplified breast cancer cell lines blocks oncogene expression and tumorigenesis.
    Oncogene. 2018 Nov 22. pii: 10.1038/s41388-018-0574.
    PubMed     Abstract available


  116. TORRES-ADORNO AM, Vitrac H, Qi Y, Tan L, et al
    Eicosapentaenoic acid in combination with EPHA2 inhibition shows efficacy in preclinical models of triple-negative breast cancer by disrupting cellular cholesterol efflux.
    Oncogene. 2018 Nov 20. pii: 10.1038/s41388-018-0569.
    PubMed     Abstract available


  117. AN J, Du Y, Fan X, Wang Y, et al
    EGFL6 promotes breast cancer by simultaneously enhancing cancer cell metastasis and stimulating tumor angiogenesis.
    Oncogene. 2018 Nov 19. pii: 10.1038/s41388-018-0565.
    PubMed     Abstract available


  118. KUMAR S, Srivastav RK, Wilkes DW, Ross T, et al
    Estrogen-dependent DLL1-mediated Notch signaling promotes luminal breast cancer.
    Oncogene. 2018 Nov 15. pii: 10.1038/s41388-018-0562.
    PubMed     Abstract available


  119. ZHAO Z, Hao D, Wang L, Li J, et al
    CtBP promotes metastasis of breast cancer through repressing cholesterol and activating TGF-beta signaling.
    Oncogene. 2018 Nov 15. pii: 10.1038/s41388-018-0570.
    PubMed     Abstract available


    September 2018
  120. BALAMURUGAN K, Mendoza-Villanueva D, Sharan S, Summers GH, et al
    C/EBPdelta links IL-6 and HIF-1 signaling to promote breast cancer stem cell-associated phenotypes.
    Oncogene. 2018 Sep 27. pii: 10.1038/s41388-018-0516.
    PubMed     Abstract available


  121. ZHU J, Zhao C, Kharman-Biz A, Zhuang T, et al
    Correction: The atypical ubiquitin ligase RNF31 stabilizes estrogen receptor alpha and modulates estrogen-stimulated breast cancer cell proliferation.
    Oncogene. 2018 Sep 27. pii: 10.1038/s41388-018-0502.
    PubMed     Abstract available


  122. ZHANG DD, Li Y, Xu Y, Kim J, et al
    Phosphodiesterase 7B/microRNA-200c relationship regulates triple-negative breast cancer cell growth.
    Oncogene. 2018 Sep 12. pii: 10.1038/s41388-018-0499.
    PubMed     Abstract available


  123. TRABOULSI T, El Ezzy M, Dumeaux V, Audemard E, et al
    Role of SUMOylation in differential ERalpha transcriptional repression by tamoxifen and fulvestrant in breast cancer cells.
    Oncogene. 2018 Sep 6. pii: 10.1038/s41388-018-0468.
    PubMed     Abstract available


  124. LIU Y, Long YH, Wang SQ, Zhang YY, et al
    JMJD6 regulates histone H2A.X phosphorylation and promotes autophagy in triple-negative breast cancer cells via a novel tyrosine kinase activity.
    Oncogene. 2018 Sep 5. pii: 10.1038/s41388-018-0466.
    PubMed     Abstract available


  125. GOTO H, Shimono Y, Funakoshi Y, Imamura Y, et al
    Adipose-derived stem cells enhance human breast cancer growth and cancer stem cell-like properties through adipsin.
    Oncogene. 2018 Sep 3. pii: 10.1038/s41388-018-0477.
    PubMed     Abstract available


  126. LI Y, Zhang H, Zhao Y, Wang C, et al
    A mandatory role of nuclear PAK4-LIFR axis in breast-to-bone metastasis of ERalpha-positive breast cancer cells.
    Oncogene. 2018 Sep 3. pii: 10.1038/s41388-018-0456.
    PubMed     Abstract available


    August 2018
  127. GUNTUKU L, Gangasani JK, Thummuri D, Borkar RM, et al
    IITZ-01, a novel potent lysosomotropic autophagy inhibitor, has single-agent antitumor efficacy in triple-negative breast cancer in vitro and in vivo.
    Oncogene. 2018 Aug 30. pii: 10.1038/s41388-018-0446.
    PubMed     Abstract available


  128. LEE E, Ouzounova M, Piranlioglu R, Ma MT, et al
    The pleiotropic effects of TNFalpha in breast cancer subtypes is regulated by TNFAIP3/A20.
    Oncogene. 2018 Aug 30. pii: 10.1038/s41388-018-0472.
    PubMed     Abstract available


  129. SARWAR M, Syed Khaja AS, Aleskandarany M, Karlsson R, et al
    The role of PIP5K1alpha/pAKT and targeted inhibition of growth of subtypes of breast cancer using PIP5K1alpha inhibitor.
    Oncogene. 2018 Aug 13. pii: 10.1038/s41388-018-0438.
    PubMed     Abstract available


  130. BONETTI P, Climent M, Panebianco F, Tordonato C, et al
    Dual role for miR-34a in the control of early progenitor proliferation and commitment in the mammary gland and in breast cancer.
    Oncogene. 2018 Aug 9. pii: 10.1038/s41388-018-0445.
    PubMed     Abstract available


  131. LORENZO-MARTIN LF, Citterio C, Menacho-Marquez M, Conde J, et al
    Vav proteins maintain epithelial traits in breast cancer cells using miR-200c-dependent and independent mechanisms.
    Oncogene. 2018 Aug 7. pii: 10.1038/s41388-018-0433.
    PubMed     Abstract available


    July 2018
  132. CASTAGNINO A, Castro-Castro A, Irondelle M, Guichard A, et al
    Coronin 1C promotes triple-negative breast cancer invasiveness through regulation of MT1-MMP traffic and invadopodia function.
    Oncogene. 2018 Jul 31. pii: 10.1038/s41388-018-0422.
    PubMed     Abstract available


  133. HUANG X, Xie X, Liu P, Yang L, et al
    Adam12 and lnc015192 act as ceRNAs in breast cancer by regulating miR-34a.
    Oncogene. 2018 Jul 24. pii: 10.1038/s41388-018-0410.
    PubMed     Abstract available


  134. ZHANG B, Lyu J, Liu Y, Wu C, et al
    BRCA1 deficiency sensitizes breast cancer cells to bromodomain and extra-terminal domain (BET) inhibition.
    Oncogene. 2018 Jul 24. pii: 10.1038/s41388-018-0408.
    PubMed     Abstract available


  135. SHI L, Tang X, Qian M, Liu Z, et al
    A SIRT1-centered circuitry regulates breast cancer stemness and metastasis.
    Oncogene. 2018 Jul 23. pii: 10.1038/s41388-018-0370.
    PubMed     Abstract available


  136. LUO L, Tang H, Ling L, Li N, et al
    LINC01638 lncRNA activates MTDH-Twist1 signaling by preventing SPOP-mediated c-Myc degradation in triple-negative breast cancer.
    Oncogene. 2018 Jul 12. pii: 10.1038/s41388-018-0396.
    PubMed     Abstract available


  137. YANG T, Ren C, Qiao P, Han X, et al
    PIM2-mediated phosphorylation of hexokinase 2 is critical for tumor growth and paclitaxel resistance in breast cancer.
    Oncogene. 2018 Jul 9. pii: 10.1038/s41388-018-0386.
    PubMed     Abstract available


  138. GUO X, Zhang Y, Mayakonda A, Madan V, et al
    ARID1A and CEBPalpha cooperatively inhibit UCA1 transcription in breast cancer.
    Oncogene. 2018 Jul 6. pii: 10.1038/s41388-018-0371.
    PubMed     Abstract available


  139. LI A, Chen P, Leng Y, Kang J, et al
    Histone deacetylase 6 regulates the immunosuppressive properties of cancer-associated fibroblasts in breast cancer through the STAT3-COX2-dependent pathway.
    Oncogene. 2018 Jul 6. pii: 10.1038/s41388-018-0379.
    PubMed     Abstract available


  140. DU WW, Yang W, Li X, Awan FM, et al
    A circular RNA circ-DNMT1 enhances breast cancer progression by activating autophagy.
    Oncogene. 2018 Jul 4. pii: 10.1038/s41388-018-0369.
    PubMed     Abstract available


  141. CUI YH, Kim H, Lee M, Yi JM, et al
    FBXL14 abolishes breast cancer progression by targeting CDCP1 for proteasomal degradation.
    Oncogene. 2018 Jul 4. pii: 10.1038/s41388-018-0372.
    PubMed     Abstract available


  142. GOLFMANN K, Meder L, Koker M, Volz C, et al
    Synergistic anti-angiogenic treatment effects by dual FGFR1 and VEGFR1 inhibition in FGFR1-amplified breast cancer.
    Oncogene. 2018 Jul 3. pii: 10.1038/s41388-018-0380.
    PubMed     Abstract available


    June 2018
  143. BROUGH R, Gulati A, Haider S, Kumar R, et al
    Identification of highly penetrant Rb-related synthetic lethal interactions in triple negative breast cancer.
    Oncogene. 2018 Jun 18. pii: 10.1038/s41388-018-0368.
    PubMed     Abstract available


  144. LEE S, Axelsen TV, Jessen N, Pedersen SF, et al
    Na(+),HCO3(-)-cotransporter NBCn1 (Slc4a7) accelerates ErbB2-induced breast cancer development and tumor growth in mice.
    Oncogene. 2018 Jun 15. pii: 10.1038/s41388-018-0353.
    PubMed     Abstract available


    May 2018
  145. LU L, Dong J, Wang L, Xia Q, et al
    Activation of STAT3 and Bcl-2 and reduction of reactive oxygen species (ROS) promote radioresistance in breast cancer and overcome of radioresistance with niclosamide.
    Oncogene. 2018 May 31. pii: 10.1038/s41388-018-0340.
    PubMed     Abstract available


  146. SIRINIAN C, Papanastasiou AD, Schizas M, Spella M, et al
    RANK-c attenuates aggressive properties of ER-negative breast cancer by inhibiting NF-kappaB activation and EGFR signaling.
    Oncogene. 2018 May 29. pii: 10.1038/s41388-018-0324.
    PubMed     Abstract available


  147. TANG J, Li Y, Sang Y, Yu B, et al
    LncRNA PVT1 regulates triple-negative breast cancer through KLF5/beta-catenin signaling.
    Oncogene. 2018 May 15. pii: 10.1038/s41388-018-0310.
    PubMed     Abstract available


  148. GALA K, Li Q, Sinha A, Razavi P, et al
    KMT2C mediates the estrogen dependence of breast cancer through regulation of ERalpha enhancer function.
    Oncogene. 2018 May 14. pii: 10.1038/s41388-018-0273.
    PubMed     Abstract available


  149. WANG PS, Chou CH, Lin CH, Yao YC, et al
    A novel long non-coding RNA linc-ZNF469-3 promotes lung metastasis through miR-574-5p-ZEB1 axis in triple negative breast cancer.
    Oncogene. 2018 May 14. pii: 10.1038/s41388-018-0293.
    PubMed     Abstract available


  150. ROGERS S, McCloy RA, Parker BL, Gallego-Ortega D, et al
    MASTL overexpression promotes chromosome instability and metastasis in breast cancer.
    Oncogene. 2018 May 10. pii: 10.1038/s41388-018-0295.
    PubMed     Abstract available


  151. PAREKH A, Das S, Parida S, Das CK, et al
    Multi-nucleated cells use ROS to induce breast cancer chemo-resistance in vitro and in vivo.
    Oncogene. 2018 May 10. pii: 10.1038/s41388-018-0272.
    PubMed     Abstract available


  152. BAKER A, Wyatt D, Bocchetta M, Li J, et al
    Notch-1-PTEN-ERK1/2 signaling axis promotes HER2+ breast cancer cell proliferation and stem cell survival.
    Oncogene. 2018 May 10. pii: 10.1038/s41388-018-0251.
    PubMed     Abstract available


  153. AHIRWAR DK, Nasser MW, Ouseph MM, Elbaz M, et al
    Fibroblast-derived CXCL12 promotes breast cancer metastasis by facilitating tumor cell intravasation.
    Oncogene. 2018 May 3. pii: 10.1038/s41388-018-0263.
    PubMed     Abstract available


  154. CHEN A, Sceneay J, Godde N, Kinwel T, et al
    Intermittent hypoxia induces a metastatic phenotype in breast cancer.
    Oncogene. 2018 May 1. pii: 10.1038/s41388-018-0259.
    PubMed     Abstract available


  155. PAVAN S, Meyer-Schaller N, Diepenbruck M, Kalathur RKR, et al
    A kinome-wide high-content siRNA screen identifies MEK5-ERK5 signaling as critical for breast cancer cell EMT and metastasis.
    Oncogene. 2018 May 1. pii: 10.1038/s41388-018-0270.
    PubMed     Abstract available


    April 2018
  156. CHANG JW, Kuo WH, Lin CM, Chen WL, et al
    Wild-type p53 upregulates an early onset breast cancer-associated gene GAS7 to suppress metastasis via GAS7-CYFIP1-mediated signaling pathway.
    Oncogene. 2018 Apr 30. pii: 10.1038/s41388-018-0253.
    PubMed     Abstract available


  157. TOOSI BM, El Zawily A, Truitt L, Shannon M, et al
    EPHB6 augments both development and drug sensitivity of triple-negative breast cancer tumours.
    Oncogene. 2018 Apr 27. pii: 10.1038/s41388-018-0228.
    PubMed     Abstract available


  158. BLANCHETTE-FARRA N, Kita D, Konstorum A, Tesfay L, et al
    Contribution of three-dimensional architecture and tumor-associated fibroblasts to hepcidin regulation in breast cancer.
    Oncogene. 2018 Apr 26. pii: 10.1038/s41388-018-0243.
    PubMed     Abstract available


  159. SUN L, Xu X, Chen Y, Zhou Y, et al
    Rab34 regulates adhesion, migration, and invasion of breast cancer cells.
    Oncogene. 2018 Apr 6. pii: 10.1038/s41388-018-0202.
    PubMed     Abstract available


    March 2018
  160. ZHANG Z, Lin G, Yan Y, Li X, et al
    Transmembrane TNF-alpha promotes chemoresistance in breast cancer cells.
    Oncogene. 2018 Mar 21. pii: 10.1038/s41388-018-0221.
    PubMed     Abstract available


  161. LIU X, Bi L, Wang Q, Wen M, et al
    miR-1204 targets VDR to promotes epithelial-mesenchymal transition and metastasis in breast cancer.
    Oncogene. 2018 Mar 20. pii: 10.1038/s41388-018-0215.
    PubMed     Abstract available


  162. WANG S, Zou Z, Luo X, Mi Y, et al
    LRH1 enhances cell resistance to chemotherapy by transcriptionally activating MDC1 expression and attenuating DNA damage in human breast cancer.
    Oncogene. 2018 Mar 16. pii: 10.1038/s41388-018-0193.
    PubMed     Abstract available


  163. STEBBING J, Shah K, Lit LC, Gagliano T, et al
    LMTK3 confers chemo-resistance in breast cancer.
    Oncogene. 2018 Mar 15. pii: 10.1038/s41388-018-0197.
    PubMed     Abstract available


  164. KIM S, Lee E, Jung J, Lee JW, et al
    microRNA-155 positively regulates glucose metabolism via PIK3R1-FOXO3a-cMYC axis in breast cancer.
    Oncogene. 2018 Mar 12. pii: 10.1038/s41388-018-0124.
    PubMed     Abstract available


    February 2018
  165. HE H, Sinha I, Fan R, Haldosen LA, et al
    c-Jun/AP-1 overexpression reprograms ERalpha signaling related to tamoxifen response in ERalpha-positive breast cancer.
    Oncogene. 2018 Feb 22. pii: 10.1038/s41388-018-0165.
    PubMed     Abstract available


  166. SIRKISOON SR, Carpenter RL, Rimkus T, Anderson A, et al
    Interaction between STAT3 and GLI1/tGLI1 oncogenic transcription factors promotes the aggressiveness of triple-negative breast cancers and HER2-enriched breast cancer.
    Oncogene. 2018 Feb 16. pii: 10.1038/s41388-018-0132.
    PubMed     Abstract available


  167. SAATCI O, Borgoni S, Akbulut O, Durmus S, et al
    Targeting PLK1 overcomes T-DM1 resistance via CDK1-dependent phosphorylation and inactivation of Bcl-2/xL in HER2-positive breast cancer.
    Oncogene. 2018 Feb 2. pii: 10.1038/s41388-017-0108.
    PubMed     Abstract available


    January 2018
  168. IRELAND L, Santos A, Campbell F, Figueiredo C, et al
    Blockade of insulin-like growth factors increases efficacy of paclitaxel in metastatic breast cancer.
    Oncogene. 2018 Jan 25. pii: 10.1038/s41388-017-0115.
    PubMed     Abstract available


  169. BROWNE AL, Charmsaz S, Vareslija D, Fagan A, et al
    Network analysis of SRC-1 reveals a novel transcription factor hub which regulates endocrine resistant breast cancer.
    Oncogene. 2018 Jan 25. pii: 10.1038/s41388-017-0042.
    PubMed     Abstract available


  170. LIANG H, Xiao J, Zhou Z, Wu J, et al
    Hypoxia induces miR-153 through the IRE1alpha-XBP1 pathway to fine tune the HIF1alpha/VEGFA axis in breast cancer angiogenesis.
    Oncogene. 2018 Jan 25. pii: 10.1038/s41388-017-0089.
    PubMed     Abstract available


  171. LIAO Y, Xia X, Liu N, Cai J, et al
    Growth arrest and apoptosis induction in androgen receptor-positive human breast cancer cells by inhibition of USP14-mediated androgen receptor deubiquitination.
    Oncogene. 2018 Jan 22. pii: 10.1038/s41388-017-0069.
    PubMed     Abstract available


  172. ZHANG Y, Wester L, He J, Geiger T, et al
    IGF1R signaling drives antiestrogen resistance through PAK2/PIX activation in luminal breast cancer.
    Oncogene. 2018 Jan 22. pii: 10.1038/s41388-017-0027.
    PubMed     Abstract available


  173. NAVANEETHAKRISHNAN S, Rosales JL, Lee KY
    Loss of Cdk5 in breast cancer cells promotes ROS-mediated cell death through dysregulation of the mitochondrial permeability transition pore.
    Oncogene. 2018 Jan 19. pii: 10.1038/s41388-017-0103.
    PubMed     Abstract available


  174. LEE GH, Yoo KC, An Y, Lee HJ, et al
    FYN promotes mesenchymal phenotypes of basal type breast cancer cells through STAT5/NOTCH2 signaling node.
    Oncogene. 2018 Jan 19. pii: 10.1038/s41388-017-0114.
    PubMed     Abstract available


  175. IKINK GJ, Boer M, Bakker ERM, Vendel-Zwaagstra A, et al
    Insertional mutagenesis in a HER2-positive breast cancer model reveals ERAS as a driver of cancer and therapy resistance.
    Oncogene. 2018 Jan 12. pii: 10.1038/s41388-017-0031.
    PubMed     Abstract available


  176. MARTINEZ-ORDONEZ A, Seoane S, Cabezas P, Eiro N, et al
    Breast cancer metastasis to liver and lung is facilitated by Pit-1-CXCL12-CXCR4 axis.
    Oncogene. 2018 Jan 11. pii: 10.1038/s41388-017-0036.
    PubMed     Abstract available


  177. MORATH I, Jung C, Leveque R, Linfeng C, et al
    Differential recruitment of CD44 isoforms by ErbB ligands reveals an involvement of CD44 in breast cancer.
    Oncogene. 2018 Jan 11. pii: 10.1038/s41388-017-0030.
    PubMed     Abstract available


    December 2017
  178. PENG F, Wang JH, Fan WJ, Meng YT, et al
    Glycolysis gatekeeper PDK1 reprograms breast cancer stem cells under hypoxia.
    Oncogene. 2017 Dec 18. pii: onc2017407. doi: 10.1038/onc.2017.
    PubMed     Abstract available


  179. HOWLEY BV, Link LA, Grelet S, El-Sabban M, et al
    A CREB3-regulated ER-Golgi trafficking signature promotes metastatic progression in breast cancer.
    Oncogene. 2017 Dec 18. pii: 10.1038/s41388-017-0023.
    PubMed     Abstract available


  180. HAN B, Zhou B, Qu Y, Gao B, et al
    FOXC1-induced non-canonical WNT5A-MMP7 signaling regulates invasiveness in triple-negative breast cancer.
    Oncogene. 2017 Dec 18. pii: 10.1038/s41388-017-0021.
    PubMed     Abstract available


  181. LUSTIG LC, Dingar D, Tu WB, Lourenco C, et al
    Inhibiting MYC binding to the E-box DNA motif by ME47 decreases tumour xenograft growth.
    Oncogene. 2017;36:6830-6837.
    PubMed     Abstract available


    November 2017
  182. PENG F, Wang JH, Fan WJ, Meng YT, et al
    Glycolysis gatekeeper PDK1 reprograms breast cancer stem cells under hypoxia.
    Oncogene. 2017 Nov 6. doi: 10.1038/onc.2017.
    PubMed     Abstract available


    October 2017
  183. LANGER EM, Kendsersky ND, Daniel CJ, Kuziel GM, et al
    ZEB1-repressed microRNAs inhibit autocrine signaling that promotes vascular mimicry of breast cancer cells.
    Oncogene. 2017 Oct 30. doi: 10.1038/onc.2017.
    PubMed     Abstract available


  184. KNOPFOVA L, Biglieri E, Volodko N, Masarik M, et al
    Transcription factor c-Myb inhibits breast cancer lung metastasis by suppression of tumor cell seeding.
    Oncogene. 2017 Oct 30. doi: 10.1038/onc.2017.
    PubMed     Abstract available


  185. LUCANUS AJ, Yip GW
    Kinesin superfamily: roles in breast cancer, patient prognosis and therapeutics.
    Oncogene. 2017 Oct 23. doi: 10.1038/onc.2017.
    PubMed     Abstract available


  186. WANG CH, Wang PJ, Hsieh YC, Lo S, et al
    Resistin facilitates breast cancer progression via TLR4-mediated induction of mesenchymal phenotypes and stemness properties.
    Oncogene. 2017 Oct 9. doi: 10.1038/onc.2017.
    PubMed     Abstract available


    September 2017
  187. XIA L, Xiao X, Liu WL, Song Y, et al
    Coactosin-like protein CLP/Cotl1 suppresses breast cancer growth through activation of IL-24/PERP and inhibition of non-canonical TGFbeta signaling.
    Oncogene. 2017 Sep 18. doi: 10.1038/onc.2017.
    PubMed     Abstract available


  188. YAMAGUCHI H, Du Y, Nakai K, Ding M, et al
    EZH2 contributes to the response to PARP inhibitors through its PARP-mediated poly-ADP ribosylation in breast cancer.
    Oncogene. 2017 Sep 18. doi: 10.1038/onc.2017.
    PubMed     Abstract available


  189. ROWSON-HODEL AR, Wald JH, Hatakeyama J, O'Neal WK, et al
    Membrane Mucin Muc4 promotes blood cell association with tumor cells and mediates efficient metastasis in a mouse model of breast cancer.
    Oncogene. 2017 Sep 11. doi: 10.1038/onc.2017.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: